John Ware to Randomized Controlled Trials as Topic
This is a "connection" page, showing publications John Ware has written about Randomized Controlled Trials as Topic.
Connection Strength
0.407
-
Frendl DM, Ware JE. Patient-reported functional health and well-being outcomes with drug therapy: a systematic review of randomized trials using the SF-36 health survey. Med Care. 2014 May; 52(5):439-45.
Score: 0.353
-
Menter A, Kosinski M, Bresnahan BW, Papp KA, Ware JE. Impact of efalizumab on psoriasis-specific patient-reported outcomes. Results from three randomized, placebo-controlled clinical trials of moderate to severe plaque psoriasis. J Drugs Dermatol. 2004 Jan-Feb; 3(1):27-38.
Score: 0.043
-
Regensteiner JG, Ware JE, McCarthy WJ, Zhang P, Forbes WP, Heckman J, Hiatt WR. Effect of cilostazol on treadmill walking, community-based walking ability, and health-related quality of life in patients with intermittent claudication due to peripheral arterial disease: meta-analysis of six randomized controlled trials. J Am Geriatr Soc. 2002 Dec; 50(12):1939-46.
Score: 0.010